PT-141
Peptiva
PT-141
ISKLJUČIVO ZA IN VITRO LABORATORIJSKA ISTRAŽIVANJA.
Nije namijenjen osobnoj, kliničkoj, dijagnostičkoj ili veterinarskoj primjeni niti primjeni na ljudima ili životinjama.
Description and specifications
What is PT-141?
PT-141, or bremelanotide, is a cyclic peptide melanocortin receptor agonist derived from melanocortin research. Unlike compounds that act directly on blood vessels, scientific interest is focused on central neural pathways.
Mechanism and scientific context
The most commonly studied mechanism is the activation of MC3R and MC4R receptors in the central nervous system. These receptors are involved in motivational, autonomic, and neuroendocrine networks, with the strength and selectivity of the response depending on the experimental model.
Main areas of research
- melanocortin signaling in the brain
- neuroendocrine and autonomic responses
- motivational and behavioral models
- agonist selectivity for receptor subtypes
How to interpret research data?
When reading literature, check the identity of the material tested, the type of model, and the limitations of the study. The existence of a paper on a molecule does not confirm the properties of this product or its batch. Findings from laboratory and animal models do not prove clinical benefit.
Available Peptiva variants
- 10 mg · Lyophilized vial
- 10 mg · Research dispenser
Select the available variant and check its name, total content, and price. The photo is not a substitute for the declaration of the selected variant.
Packaging format and content
Research dispenser: the variant contains a complete pre-filled dispenser with the selected content, not just a separate replacement cartridge. The quantity indicated with the variant refers to the total declared content, not the amount per individual use.
Lyophilized vial: the variant contains lyophilized material in a vial, without a dispenser. This description does not refer to bacteriostatic water or a separate empty container.
Storage and handling conditions depend on the specific formulation and batch declaration. The packaging format does not confirm sterility, dosing accuracy, stability, or suitability for human or animal use.
Important limitations
The existence of an approved drug with this active substance does not mean that the research product is a drug or that it should be used in the same way.
Batch documentation
For inquiries about available COA documentation, please contact peptivacomhr@gmail.com with the product name and LOT number, if known. Availability and scope of analyses are checked for the specific batch. The COA does not, by itself, prove sterility or suitability for human or animal use.
Intended use and limitations: The product is intended exclusively for laboratory research. It is not intended for use in humans or animals, for diagnosing, treating, mitigating, or preventing diseases. The description is not medical advice. The research-use-only label and packaging name do not, by themselves, determine the regulatory status of the product or prove its safety or sterility.
COA on request
To enquire about a certificate of analysis (COA), send the material name, requested variant and LOT / batch number if available. Documents are not published on this page.
Request a COA by emailThe button opens your email app with a prepared enquiry. You send the message yourself. peptivacomhr@gmail.com
A COA applies to a specific batch. A purity result alone does not establish sterility, absence of endotoxins or safety for use in humans or animals.